MOTS-c

Also known as Mitochondrial ORF of the 12S rRNA type-c

Mitochondrial-derived peptideEvidence tier D

MOTS-c is a small peptide (16 amino acids) encoded in mitochondrial DNA — the DNA inside a cell’s energy-producing structures — rather than the main nuclear DNA. That makes it part of a newly identified class called “mitochondrial-derived peptides.”

In rodent studies, researchers found MOTS-c produced exercise-like metabolic effects: better insulin sensitivity and muscle adaptation under exercise or calorie stress.

No published human trial has tested MOTS-c for exercise performance, injury recovery, or any musculoskeletal use — the evidence sits entirely in animal and lab-dish work. That gap matters more than usual here: researchers have found that promising metabolic and exercise-mimicking results in rodents frequently fail to reproduce once tested in people.[1] “Exercise mimetic” describes an animal-study finding about MOTS-c, not a proven human effect.

References

  1. Pound P, Ritskes-Hoitinga M. Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail. J Transl Med. 2018. Source.